Gene therapy patients monitored for years in new Follow-Up study
NCT ID NCT06798298
First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times
Summary
This study follows up to 50 people who previously received gene-modified T cell therapy in another trial. No new treatment is given. Researchers will check for delayed side effects, how long the modified cells last, and overall health. The goal is to better understand long-term safety and effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG TERM SAFETY FOLLOWING GM T CELL THERAPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tennessee Oncology
RECRUITINGNashville, Tennessee, 37203, United States